Skip to main content

Nicotine Dependence and Cardiovascular Diseases: Biobehavioral and Psychosocial Correlates

  • Reference work entry
  • First Online:
Handbook of Cardiovascular Behavioral Medicine

Abstract

Tobacco use is the most preventable cause of premature death in the United States. Cigarette smoking increases the risk of coronary heart disease, stroke, and peripheral arterial disease. The link between pathology and tobacco use has been established through accumulating evidence over four decades demonstrating a dose-response relationship between cigarette smoking (amount and duration) and risk for cardiovascular diseases. This chapter will review examples of research demonstrating acute and chronic effects of smoking on cardiovascular function, the interaction of nicotine effects and stress, long-term effects of cigarette smoking on cardiovascular disease risk, and mechanisms mediating effects of cigarettes smoking on cardiovascular disease. In addition, a review of moderating factors, available intervention options to address smoking, and benefits of cessation on cardiovascular health will be undertaken. The article concludes with a summary of current research findings of the link between tobacco use and cardiovascular disease and future directions.

Lorentz Wittmers: deceased.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 549.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Adler N, Ostrove J (1999) Socioeconomic status and health: what we know and what we don’t. Ann N Y Acad Sci 896(1):3–15

    Article  PubMed  Google Scholar 

  2. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher A, Dimmeler S (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9:1370–1376

    Article  PubMed  Google Scholar 

  3. Al’Absi M, Bongard S, Buchanan T, Pincomb G, Licinio J, Lovallo W (1997) Cardiovascular and neuroendocrine adjustment to public speaking and mental arithmetic stressors. Psychophysiology 34(3):266–275

    Article  PubMed  Google Scholar 

  4. al’Absi M, Amunrud T, Wittmers L (2002) Psychophysiological effects of nicotine abstinence and behavioral challenges in habitual smokers. Pharmacol Biochem Behav 72:707–716

    Article  PubMed  Google Scholar 

  5. al’Absi M, Wittmers L, Erickson J, Hatsukami D, Crouse B (2003) Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers. Pharmacol Biochem Behav 74(2):401–410

    Article  PubMed  Google Scholar 

  6. al’Absi M, Hatsukami D, Davis G, Wittmers L (2004) Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend 73:267–278

    Article  PubMed  Google Scholar 

  7. al’Absi M, Hatsukami D, Davis G (2005) Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology 181:107–117

    Article  PubMed  Google Scholar 

  8. al’Absi M, Wittmers L, Hatsukami D, Westra R (2008) Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke. Psychosom Med 70:928–935

    Article  PubMed  PubMed Central  Google Scholar 

  9. al’Absi M, Hooker S, Fujiwara K, Kiefer F, von der Goltz C, Cragin T, Wittmers LE (2011) Circulating leptin levels are associated with increased craving to smoke in abstinent smokers. Pharmacol Biochem Behav 97:509–513

    Article  PubMed  Google Scholar 

  10. al’Absi M, Lemieux A, Nakajima M (2014) Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers. Psychoneuroendocrinology 49:253–259

    Article  PubMed  PubMed Central  Google Scholar 

  11. Aldoori M, Rahman S (1998) Smoking and stroke: a causative role. Br Med J 317:962

    Article  Google Scholar 

  12. Anderson EW, Andelman RJ, Strauch JM, Fortuin NJ, Knelson JH (1973) Effect of low-level carbon monoxide exposure on onset and duration of angina pectoris. A study in ten patients with ischemic heart disease. Ann Intern Med 79:46–50

    Article  PubMed  Google Scholar 

  13. Anthony J, Warner L, Kessler R (1994) Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 2(3):244–268

    Article  Google Scholar 

  14. Ashby DT, Dangas G, Mehran R, Lansky AJ, Fahy MP, Iakovou I (2002) Comparison of one-year outcomes after percutaneous coronary intervention among current smokers, ex-smokers, and nonsmokers. Am J Cardiol 89:221–224

    Article  PubMed  Google Scholar 

  15. Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P (2012) Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 345:e4439

    Article  PubMed  PubMed Central  Google Scholar 

  16. Baum A, Garofalo JP, Yali AM (1999) Socioeconomic status and chronic stress. Does stress account for SES effects on health? Ann N Y Acad Sci 896:131–144

    Article  PubMed  Google Scholar 

  17. Benowitz NL (1988) Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 319:1318–1330

    Article  PubMed  Google Scholar 

  18. Benowitz NL (1992) Cigarette smoking and nicotine addiction. Med Clin North Am 76:415–437

    Article  PubMed  Google Scholar 

  19. Benowitz NL (1996) Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol 36:597–613

    Article  PubMed  Google Scholar 

  20. Benowitz NL (2003) Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis 46:91–9111

    Article  PubMed  Google Scholar 

  21. Benowitz N (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ben-Shlomo Y, Smith GD, Shipley MJ, Marmot MG (1994) What determines mortality risk in male former cigarette smokers? Am J Public Health 84:1235–1242

    Article  PubMed  PubMed Central  Google Scholar 

  23. Blanchard JF, Armenian HK, Friesen PP (2000) Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 151:575–583

    Article  PubMed  Google Scholar 

  24. Bosma H, Peter R, Siegrist J, Marmot M (1998) Two alternative job stress models and the risk of coronary heart disease. Am J Public Health 88:68–74

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bovet P, Perret F, Cornuz J, Quilindo J, Paccaud F (2002) Improved smoking cessation in smokers given ultrasound photographs of their own atherosclerotic plaques. Prev Med 34:215–220

    Article  PubMed  Google Scholar 

  26. Burgess ES, Brown RA, Kahler CW, Niaura R, Abrams DB, Goldstein MG, Miller IW (2002) Patterns of change in depressive symptoms during smoking cessation: who’s at risk for relapse? J Consult Clin Psychol 70:356–361

    Article  PubMed  PubMed Central  Google Scholar 

  27. Burns DM (2003) Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 46:11–29

    Article  PubMed  Google Scholar 

  28. Cacciola RR, Guarino F, Polosa R (2007) Relevance of endothelial-haemostatic dysfunction in cigarette smoking. Curr Med Chem 14:1887–1892

    Article  PubMed  Google Scholar 

  29. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097–1105

    Article  PubMed  Google Scholar 

  30. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  31. Calnan M (1989) Control over health and patterns of health-related behaviour. Soc Sci Med 29:131–136

    Article  PubMed  Google Scholar 

  32. Campbell S, Moffatt R, Stamford B (2008) Smoking and smoking cessation – the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 20:225–235

    Article  Google Scholar 

  33. Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N, Khaw KT (2005) Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res 13(8):1466–1475

    Article  PubMed  Google Scholar 

  34. Carnethon MR, Lynch EB, Dyer AR, Lloyd-Jones DM, Wang R, Garside DB, Greenland P (2006) Comparison of risk factors for cardiovascular mortality in black and white adults. Arch Intern Med 166:1196–1202

    Article  PubMed  Google Scholar 

  35. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149–2155

    Article  PubMed  Google Scholar 

  36. Centers for Disease Control and Prevention (2004) Prevalence of cigarette use among 14 racial/ethnic populations – United States, 1999–2001. Morb Mortal Wkly Rep 53(3):49–52

    Google Scholar 

  37. Centers for Disease Control and Prevention (2005) Racial/ethnic and socioeconomic disparities in multiple risk factors for heart disease and stroke – United States, 2003. Morb Mortal Wkly Rep 54(5):113–117

    Google Scholar 

  38. Chuang Y-C, Cubbin C, Ahn D, Winkleby MA (2005) Effects of neighbourhood socioeconomic status and convenience store concentration on individual level smoking. J Epidemiol Community Health 59:568–573

    Article  PubMed  PubMed Central  Google Scholar 

  39. Craig WY, Palomaki GE, Haddow JE (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298:784–788

    Article  PubMed  PubMed Central  Google Scholar 

  40. Critchley J, Capewell S (2003) Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database of Syst Rev 14583958

    Google Scholar 

  41. Czernin J, Waldherr C (2003) Cigarette smoking and coronary blood flow. Prog Cardiovasc Dis 45:395–404

    Article  PubMed  Google Scholar 

  42. Daughton DM, Fortmann SP, Glover ED, Hatsukami DK, Heatley SA, Lichtenstein E, Repsher L, Millatmal T, Killen JD, Nowak RT, Ullrich F, Patil KD, Rennard SI (1999) The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med 28:113–118

    Article  PubMed  Google Scholar 

  43. Deanfield JE, Shea MJ, Wilson RA, Horlock P, de Landsheere CM, Selwyn AP (1986) Direct effects of smoking on the heart: silent ischemic disturbances of coronary flow. Am J Cardiol 57:1005–1009

    Article  PubMed  Google Scholar 

  44. Dembroski TM, MacDougall JM, Cardozo SR, Ireland SK, Krug-Fite J (1985) Selective cardiovascular effects of stress and cigarette smoking in young women. Health Psychol 4:153–167

    Article  PubMed  Google Scholar 

  45. Dunner DL, Zisook S, Billow AA, Batey SR, Johnston JA, Ascher JA (1998) A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. J Clin Psychiatry 59:366–373

    Article  PubMed  Google Scholar 

  46. Eachus J, Williams M, Chan P, Smith GD, Grainge M, Donovan J, Frankel S (1996) Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ 312:287–292

    Article  PubMed  PubMed Central  Google Scholar 

  47. Eames M, Ben-Shlomo Y, Marmot MG (1993) Social deprivation and premature mortality: regional comparison across England. BMJ 307:1097–1102

    Article  PubMed  PubMed Central  Google Scholar 

  48. Erhardt L (2009) Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis 205:23–32

    Article  PubMed  Google Scholar 

  49. Fagan P, Moolchan ET, Lawrence D, Fernander A, Ponder PK (2007) Identifying health disparities across the tobacco continuum. Addiction 102(Suppl 2):5–29

    Article  PubMed  Google Scholar 

  50. Fagerström K, Schneider N, Lunell E (1993) Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology 111(3):271–277

    Article  PubMed  Google Scholar 

  51. Filozof C, Fernandez Pinilla MC, Fernandez-Cruz A (2004) Smoking cessation and weight gain. Obes Rev 5(2):95–103

    Article  PubMed  Google Scholar 

  52. Fiore M, Smith S, Jorenby D, Baker T (1994) The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 271:1940

    Article  PubMed  Google Scholar 

  53. Freedman DM, Sigurdson AJ, Rajaraman P, Doody MM, Linet MS, Ron E (2006) The mortality risk of smoking and obesity combined. Am J Prev Med 31:355–362

    Article  PubMed  Google Scholar 

  54. Garvey AJ, Bliss RE, Hitchcock JL, Heinold JW, Rosner B (1992) Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict Behav 17:367–377

    Article  PubMed  Google Scholar 

  55. Gilman SE, Abrams DB, Buka SL (2003) Socioeconomic status over the life course and stages of cigarette use: initiation, regular use, and cessation. J Epidemiol Community Health 57:802–808

    Article  PubMed  PubMed Central  Google Scholar 

  56. Giovino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J (1995) Epidemiology of tobacco use and dependence. Epidemiol Rev 17:48–65

    Article  PubMed  Google Scholar 

  57. Glantz SA, Parmley WW (1995) Passive smoking and heart disease. Mechanisms and risk. JAMA 273:1047–1053

    Article  PubMed  Google Scholar 

  58. Glassman A (1993) Cigarette smoking: implications for psychiatric illness. Am J Psychiatr 150:546

    Article  PubMed  Google Scholar 

  59. Gonzales DH, Nides MA, Ferry LH, Kustra RP, Jamerson BD, Segall N, Herrero LA, Krishen A, Sweeney A, Buaron K, Metz A (2001) Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clin Pharmacol Ther 69:438–444

    Article  PubMed  Google Scholar 

  60. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR (2006) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 296:47–55

    Article  PubMed  Google Scholar 

  61. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A (1999) Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med 159:2033–2038

    Article  PubMed  Google Scholar 

  62. Hall SM, Munoz RF, Reus VI, Sees KL (1993) Nicotine, negative affect, and depression. J Consult Clin Psychol 61:761–767

    Article  PubMed  Google Scholar 

  63. Hallstrom AP, Cobb LA, Ray R (1986) Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 314:271–275

    Article  PubMed  Google Scholar 

  64. Hammett CJK, Prapavessis H, Baldi JC, Ameratunga R, Schoenbeck U, Varo N, French JK, White HD, Stewart RAH (2007) Variation in blood levels of inflammatory markers related and unrelated to smoking cessation in women. Prev Cardiol 10:68–75

    Article  PubMed  Google Scholar 

  65. Hanson MD, Chen E (2007) Socioeconomic status and health behaviors in adolescence: a review of the literature. J Behav Med 30:263–285

    Article  PubMed  Google Scholar 

  66. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y (1989) Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 79:245–252

    Article  PubMed  Google Scholar 

  67. Harper S, Lynch J (2007) Trends in socioeconomic inequalities in adult health behaviors among U.S. states, 1990–2004. Public Health Rep 122:177–189

    Article  PubMed  PubMed Central  Google Scholar 

  68. Harwood GA, Salsberry P, Ferketich AK, Wewers ME (2007) Cigarette smoking, socioeconomic status, and psychosocial factors: examining a conceptual framework. Public Health Nurs 24:361–371

    Article  PubMed  Google Scholar 

  69. Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Johnston JA, White JD (2001) Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial. Ann Intern Med 135:423–433

    Article  PubMed  Google Scholar 

  70. He J, Ogden L, Bazzano L, Vupputuri S, Loria C, Whelton P (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161(7):996

    Article  PubMed  Google Scholar 

  71. Heitzer T, Yla-Herttuala S, Luoma J, Kurz S, Munzel T, Just H, Olschewski M, Drexler H (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93:1346–1353

    Article  PubMed  Google Scholar 

  72. Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43(3):289–294

    Article  PubMed  Google Scholar 

  73. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195–1202

    Article  PubMed  Google Scholar 

  74. Iribarren C, Luepker RV, McGovern PG, Arnett DK, Blackburn H (1997) Twelve-year trends in cardiovascular disease risk factors in the Minnesota Heart Survey. Are socioeconomic differences widening? Arch Intern Med 157:873–881

    Article  PubMed  Google Scholar 

  75. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R (2013) 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368(4):341–350

    Article  PubMed  Google Scholar 

  76. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685–691

    Article  PubMed  Google Scholar 

  77. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR (2006) Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296:56–63

    Article  PubMed  Google Scholar 

  78. Joseph AM, Fu SS (2003) Smoking cessation for patients with cardiovascular disease: what is the best approach? Am J Cardiovasc Drugs 3:339–349

    Article  PubMed  Google Scholar 

  79. Kannel WB (2005) Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 40:1215–1220

    Article  PubMed  Google Scholar 

  80. Kaplan GA, Keil JE (1993) Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 88:1973–1998

    Article  PubMed  Google Scholar 

  81. Kaplan GA, Salonen JT (1990) Socioeconomic conditions in childhood and ischaemic heart disease during middle age. BMJ 301:1121–1123

    Article  PubMed  PubMed Central  Google Scholar 

  82. Kenford SL, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB (2002) Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol 70:216–227

    Article  PubMed  Google Scholar 

  83. Killen JD, Fortmann SP, Newman B, Varady A (1990) Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 58:85–92

    Article  PubMed  Google Scholar 

  84. Kirschbaum C, Strasburger CJ, Langkrar J (1993) Attenuated cortisol response to psychological stress but not to CRH or ergometry in young habitual smokers. Pharmacol Biochem Behav 44:527–531

    Article  PubMed  Google Scholar 

  85. Klesges RC, Elliott VE, Robinson LA (1997) Chronic dieting and the belief that smoking controls body weight in a biracial, population-based adolescent sample. Tob Control 6(2):89–94

    Article  PubMed  PubMed Central  Google Scholar 

  86. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, Inden Y, Murohara T (2004) Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 24:1442–1447

    Article  PubMed  Google Scholar 

  87. Kool MJ, Hoeks AP, Struijker Boudier HA, Reneman RS, Van Bortel LM (1993) Short- and long-term effects of smoking on arterial wall properties in habitual smokers. J Am Coll Cardiol 22:1881–1886

    Article  PubMed  Google Scholar 

  88. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G (1995) Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 24:41–47

    Article  PubMed  Google Scholar 

  89. Koster A, Leitzmann MF, Schatzkin A, Adams KF, van Eijk JT, Hollenbeck AR, Harris TB (2008) The combined relations of adiposity and smoking on mortality. Am J Clin Nutr 88:1206–1212

    PubMed  Google Scholar 

  90. Krupski W (1991) The peripheral vascular consequences of smoking. Ann Vasc Surg 5(3):291–304

    Article  PubMed  Google Scholar 

  91. Kurihara S (1995) Effect of age on blood pressure response to cigarette smoking. Cardiology 86:102–107

    Article  PubMed  Google Scholar 

  92. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH (1991) Smoking and mortality among older men and women in three communities. N Engl J Med 324:1619–1625

    Article  PubMed  Google Scholar 

  93. Lando HA, Pirie PL, Roski J, McGovern PG, Schmid LA (1996) Promoting abstinence among relapsed chronic smokers: the effect of telephone support. Am J Public Health 86:1786–1790

    Article  PubMed  PubMed Central  Google Scholar 

  94. Lemieux A, Nakajima M, Hatsukami DK, Allen S, al’Absi M (2015) Changes in circulating leptin levels during the initial stage of cessation are associated with smoking relapse. Psychopharmacology 232:3355–3361

    Article  PubMed  PubMed Central  Google Scholar 

  95. Leone A (2005) Biochemical markers of cardiovascular damage from tobacco smoke. Curr Pharm Des 11(17):2199–2208

    Article  PubMed  Google Scholar 

  96. Levine MD, Perkins KA, Marcus MD (2001) The characteristics of women smokers concerned about postcessation weight gain. Addict Behav 26:749–756

    Article  PubMed  Google Scholar 

  97. Lost P, Costs – United E (2002) Annual smoking-attributable mortality, years of potential life lost, and economic costs – United States, 1995–1999. JAMA 287(18):2355

    Article  Google Scholar 

  98. Ludvig J, Miner B, Eisenberg MJ (2005) Smoking cessation in patients with coronary artery disease. Am Heart J 149:565–572

    Article  PubMed  Google Scholar 

  99. Lynch J, Krause N, Kaplan GA, Tuomilehto J, Salonen JT (1997) Workplace conditions, socioeconomic status, and the risk of mortality and acute myocardial infarction: the Kuopio Ischemic Heart Disease Risk Factor Study. Am J Public Health 87:617–622

    Article  PubMed  PubMed Central  Google Scholar 

  100. MacDougall JM, Musante L, Castillo S, Acevedo MC (1988) Smoking, caffeine, and stress: effects on blood pressure and heart rate in male and female college students. Health Psychol 7:461–478

    Article  PubMed  Google Scholar 

  101. Mahmud A, Feely J (2003) Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 41:183–187

    Article  PubMed  Google Scholar 

  102. Mahonen MS, McElduff P, Dobson AJ, Kuulasmaa KA, Evans AE (2004) Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations. Tob Control 13:244–250

    Article  PubMed  PubMed Central  Google Scholar 

  103. Maytin M, Leopold J, Loscalzo J (1999) Oxidant stress in the vasculature. Curr Atheroscler Rep 1:156–164

    Article  PubMed  Google Scholar 

  104. McBride PE (1992) The health consequences of smoking. Cardiovascular diseases. Med Clin North Am 76(1548965):333–353

    Article  PubMed  Google Scholar 

  105. Moreno H, Chalon S, Urae A, Tangphao O, Abiose AK, Hoffman BB, Blaschke TF (1998) Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation. Am J Physiol 275:1040–1045

    Google Scholar 

  106. Morita H, Ikeda H, Haramaki N, Eguchi H, Imaizumi T (2005) Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J Am Coll Cardiol 45:589–594

    Article  PubMed  Google Scholar 

  107. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332:1198–1203

    Article  PubMed  Google Scholar 

  108. Nakamura M, Oshima A, Fujimoto Y, Maruyama N, Ishibashi T, Reeves KR (2007) Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther 29:1040–1056

    Article  PubMed  Google Scholar 

  109. Nelson DE, Emont SL, Brackbill RM, Cameron LL, Peddicord J, Fiore MC (1994) Cigarette smoking prevalence by occupation in the United States. A comparison between 1978 to 1980 and 1987 to 1990. J Occup Med 36:516–525

    PubMed  Google Scholar 

  110. Niederdeppe J, Kuang X, Crock B, Skelton A (2008) Critical steps in building the evidence base regarding media campaign effects on disadvantaged populations: a response to Fagan. Soc Sci Med 67:1359–1360

    Article  PubMed  Google Scholar 

  111. Notkola V, Punsar S, Karvonen MJ, Haapakoski J (1985) Socio-economic conditions in childhood and mortality and morbidity caused by coronary heart disease in adulthood in rural Finland. Soc Sci Med 21:517–523

    Article  PubMed  Google Scholar 

  112. Ockene IS, Miller NH (1997) Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 96:3243–3247

    Article  PubMed  Google Scholar 

  113. Ohkubo C (1982) Some acute cardiopulmonary effects of mainstream and sidestream cigarette smoke in man. Prev Med 11:173–186

    Article  PubMed  Google Scholar 

  114. Penn A, Chen LC, Snyder CA (1994) Inhalation of steady-state sidestream smoke from one cigarette promotes arteriosclerotic plaque development. Circulation 90:1363–1367

    Article  PubMed  Google Scholar 

  115. Petersen KL, Bleil ME, McCaffery J, Mackey RH, Sutton-Tyrrell K, Muldoon MF, Manuck SB (2006) Community socioeconomic status is associated with carotid artery atherosclerosis in untreated, hypertensive men. Am J Hypertens 19:560–566

    Article  PubMed  Google Scholar 

  116. Pickering T (1999) Cardiovascular pathways: socioeconomic status and stress effects on hypertension and cardiovascular function. Ann N Y Acad Sci 896(1):262–277

    Article  PubMed  Google Scholar 

  117. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM (1989) Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA 261:61–65

    Article  PubMed  Google Scholar 

  118. Pisinger C, Jorgensen T (2007) Weight concerns and smoking in a general population: the Inter99 study. Prev Med 44:283–289

    Article  PubMed  Google Scholar 

  119. Pittilo RM, Clarke JM, Harris D, Mackie IJ, Rowles PM, Machin SJ, Woolf N (1984) Cigarette smoking and platelet adhesion. Br J Haematol 58:627–632

    Article  PubMed  Google Scholar 

  120. Pomerleau OF, Pomerleau CS (1991) Research on stress and smoking: progress and problems. Br J Addict 86:599–603

    Article  PubMed  Google Scholar 

  121. Pomerleau CS, Zucker AN, Stewart AJ (2001) Characterizing concerns about post-cessation weight gain: results from a national survey of women smokers. Nicotine Tob Res 3:51–60

    Article  PubMed  Google Scholar 

  122. Pontieri F, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255–257

    Article  PubMed  Google Scholar 

  123. Potretzke S, Nakajima M, Cragin T, al’Absi M (2014) Changes in circulating leptin levels during acute stress and associations with craving in abstinent smokers: a preliminary investigation. Psychoneuroendocrinology 47:232–240

    Article  PubMed  PubMed Central  Google Scholar 

  124. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL, Lopez AG, Winniford MD (1993) Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 22:642–647

    Article  PubMed  Google Scholar 

  125. Reichert V, Xue X, Bartscherer D, Jacobsen D, Fardellone C, Folan P, Kohn N, Talwar A, Metz CN (2009) A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease. Chest 136:212–219

    Article  PubMed  PubMed Central  Google Scholar 

  126. Rigotti NA, Pasternak RC (1996) Cigarette smoking and coronary heart disease: risks and management. Cardiol Clin 14:51–68

    Article  PubMed  Google Scholar 

  127. Rosenberg L, Palmer JR, Shapiro S (1990) Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 322:213–217

    Article  PubMed  Google Scholar 

  128. Rosengren A, Orth-Gomer K, Wilhelmsen L (1998) Socioeconomic differences in health indices, social networks and mortality among Swedish men. A study of men born in 1933. Scand J Soc Med 26:272–280

    Article  PubMed  Google Scholar 

  129. Shah PK, Helfant RH (1988) Smoking and coronary artery disease. Chest 94:449–452

    Article  PubMed  Google Scholar 

  130. Shaw D, al’Absi M (2008) Attenuated beta endorphin response to acute stress is associated with smoking relapse. Pharmacol Biochem Behav 90:357–362

    Article  PubMed  PubMed Central  Google Scholar 

  131. Shiffman S, West R, Gilbert D (2004) Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res 6(4):599–614

    Article  PubMed  Google Scholar 

  132. Shiffman S, Hughes JR, Ferguson SG, Pillitteri JL, Gitchell JG, Burton SL (2007) Smokers’ interest in using nicotine replacement to aid smoking reduction. Nicotine Tob Res 9:1177–1182

    Article  PubMed  Google Scholar 

  133. Shinton R, Beevers G (1989) Meta-analysis of relation between cigarette smoking and stroke. BMJ 298:89–794

    Article  Google Scholar 

  134. Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295:321–327

    PubMed  Google Scholar 

  135. Stronks K, van de Mheen HD, Looman CW, Mackenbach JP (1997) Cultural, material, and psychosocial correlates of the socioeconomic gradient in smoking behavior among adults. Prev Med 26:754–766

    Article  PubMed  Google Scholar 

  136. Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 357:1571–1575

    Article  PubMed  Google Scholar 

  137. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368:647–658

    Article  PubMed  Google Scholar 

  138. Tian J, Venn A, Otahal P, Gall S (2015) The association between quitting smoking and weight gain: a systemic review and meta-analysis of prospective cohort studies. Obes Rev 16(10):883–901

    Article  PubMed  Google Scholar 

  139. Tonstad S, Andrew Johnston J (2006) Cardiovascular risks associated with smoking: a review for clinicians. Eur J Cardiovasc Prev Rehabil 13(4):507

    Article  PubMed  Google Scholar 

  140. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M (2002) Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 105:1155–1157

    Article  PubMed  Google Scholar 

  141. Turner RJ, Lloyd DA (1999) The stress process and the social distribution of depression. J Health Soc Behav 40:374–404

    Article  PubMed  Google Scholar 

  142. Tverdal A, Thelle D, Stensvold I, Leren P, Bjartveit K (1993) Mortality in relation to smoking history: 13 years’ follow-up of 68,000 Norwegian men and women 35–49 years. J Clin Epidemiol 46:475–487

    Article  PubMed  Google Scholar 

  143. U. S. Department of Health and Human Services (1990) The health benefits of smoking cessation: a report of the Surgeon General. U.S. Department of Health and Human Services

    Google Scholar 

  144. U.S. Department of Health and Human Services (1998) Tobacco use among U.S. racial/ethnic minority groups – African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, Hispanics. A Report of the Surgeon General. Executive summary. MMWR Recomm Rep 47(RR-18):v-16

    Google Scholar 

  145. U.S. Department of Health and Human Services (2004) The health consequences of smoking: a report of the surgeon general. U.S. Department of Health and Human Services

    Google Scholar 

  146. U.S. Department of Health and Human Services (2014) The health consequences of smoking: 50 years of progress. A report of the Surgeon General. Department of Health and Human, Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health

    Google Scholar 

  147. Voors A, van Brussel B, Thijs Plokker H, Ernst S, Ernst N, Koomen E, Tijssen J, Vermeulen F (1996) Smoking and cardiac events after venous coronary bypass surgery: a 15-year follow-up study. Circulation 93(1):42

    Article  PubMed  Google Scholar 

  148. Wannamethee SG, Lowe GDO, Shaper AG, Rumley A, Lennon L, Whincup PH (2005) Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 26:1765–1773

    Article  PubMed  Google Scholar 

  149. Ye J, Rust G, Baltrus P, Daniels E (2009) Cardiovascular risk factors among Asian Americans: results from a National Health Survey. Ann Epidemiol 19:718–723

    Article  PubMed  Google Scholar 

  150. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB (2008) Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117(13):1658–1667

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mustafa al’Absi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

al’Absi, M., Nakajima, M., Green, P., Petersen, K., Wittmers, L. (2022). Nicotine Dependence and Cardiovascular Diseases: Biobehavioral and Psychosocial Correlates. In: Waldstein, S.R., Kop, W.J., Suarez, E.C., Lovallo, W.R., Katzel, L.I. (eds) Handbook of Cardiovascular Behavioral Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-85960-6_12

Download citation

Publish with us

Policies and ethics